期刊文献+

Automated Behavioral Phenotyping Reveals Presymptomatic Alterations in a SCA3 Genetrap Mouse Model 被引量:1

Automated Behavioral Phenotyping Reveals Presymptomatic Alterations in a SCA3 Genetrap Mouse Model
原文传递
导出
摘要 Characterization of disease models of neurodegenerative disorders requires a systematic and comprehensive phenotyping in a highly standardized manner. Therefore, automated high-resolution behavior test systems such as the homecage based LabMaster system are of particular interest. We demonstrate the power of the automated LabMaster system by discovering previously unrecognized features of a recently characterized atxn3 mutant mouse model. This model provided neurological symptoms including gait ataxia, tremor, weight loss and premature death at the age of 12 months usually detectable just 2 weeks before the mice died. Moreover, using the LabMaster system we were able to detect hypoactivity in presymptomatic mutant mice in the dark as well as light phase. Additionally, we analyzed inflammation, immunological and hematological parameters, which indicated a reduced immune defense in phenotypic mice. Here we demonstrate that a detailed characterization even of organ systems that are usually not affected in SCA3 is important for further studies of pathogenesis and required for the preclinical therapeutic studies. Characterization of disease models of neurodegenerative disorders requires a systematic and comprehensive phenotyping in a highly standardized manner. Therefore, automated high-resolution behavior test systems such as the homecage based LabMaster system are of particular interest. We demonstrate the power of the automated LabMaster system by discovering previously unrecognized features of a recently characterized atxn3 mutant mouse model. This model provided neurological symptoms including gait ataxia, tremor, weight loss and premature death at the age of 12 months usually detectable just 2 weeks before the mice died. Moreover, using the LabMaster system we were able to detect hypoactivity in presymptomatic mutant mice in the dark as well as light phase. Additionally, we analyzed inflammation, immunological and hematological parameters, which indicated a reduced immune defense in phenotypic mice. Here we demonstrate that a detailed characterization even of organ systems that are usually not affected in SCA3 is important for further studies of pathogenesis and required for the preclinical therapeutic studies.
出处 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2012年第6期287-299,共13页 遗传学报(英文版)
基金 supported by the European Union to OR(6th frame work programme.EuroSCA)
关键词 Automated homecage behavior Genetrap mouse model Spinocerebellar Ataxia Type 3 Automated homecage behavior Genetrap mouse model Spinocerebellar Ataxia Type 3
  • 相关文献

参考文献38

  • 1Andrade, V.S., Rojas, D.B., Oliveira, L., Nunes, M.L., de Castro, F.L., Garcia, C., Gemelli, T., de Andrade, R.B., Wannmacher, C.M., 2012. Creatine and pyruvate prevent behavioural and oxidative stress alterations caused by hypertryptophanemia in rats. Mol. Cell. Biochem. 362, 225-232.
  • 2Arndt, S.S., Surjo, D., 2001. Methods for the behavioural phenotyping of mouse mutants. How to keep the overview. Behav. Brain Res. 125, 39--42.
  • 3Bichelmeier, U., Schmidt, T., Hiibener, J., Boy, J., Rtittiger, L., H/ibig, K., Poths, S., Bonin, M., Knipper, M., Schmidt, W.J., Wilbertz, J., Wolburg, H., Laccone, F., Riess, O., 2007. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J. Neurosci. 27, 7418--7428.
  • 4Bierer, B.E., Sleckman, B.E, Ratnofsky, S.E., Burakoff, S.J., 1989. The bio- logic roles of CD2, CD4, and CD8 in T-cell activation. Annu. Rev. Immunol. 7, 579-599.
  • 5Bjtirkqvist, M,, Wild, E.J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R.V., Benn, C.L., Soulet, D., Magnusson, A., Woodman, B., Landles, C., Pouladi, M.A., Hayden, M.R., Khalili-Shirazi, A., Lowdell, M.W., Bmndin, E, Bates, G.E, Leavitt, B.R., M611er, T., Tabrizi, S.J., 2008. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J. Exp. Med. 205, 1869--1877.
  • 6Brown, S.D., Chambon, E, de Angelis, M.H., 2005. EMPRESS: standardized phenotype screens for functional annotation of the mouse genome. Nat. Genet. 37, 1155.
  • 7Crawley, J.N., 2003, Behavioral phenotyping of rodents. Comp. Med. 53, 140-146.
  • 8Cobbold, S.R, Jayasuriya, A., Nash, A., Prospero, T.D., Waldmann, H., 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312, 548--551.
  • 9Davies, N.W., Guillemin, G., Brew, B.J., 2010. Tryptopban, neurodegeneration and HIV-associated neurocognitive disorder. Int. J. Tryptophan Res. 3, 121--140.
  • 10Evert, B.O., Vogt, I.R., Kindermann, C., Ozimek, L., de Vos, R.A., Brunt, E.R., Schmitt, I., Klockgether, T., Wiillner, U., 2001. Inflammatory genes are upregulated in expanded ataxin-3 expressing cell lines and Spinocerebellar Ataxia Type 3 brains. J. Neurosci. 21, 5389--5396.

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部